IsisCB Explore

Article ID: CBB001420651

Farmacologia no século XX: a ciência dos medicamentos a partir da análise do livro de Goodman e Gilman (2013)

Bittencourt, Silvia Cardoso (Author)
Caponi, Sandra (Author)
Maluf, Sonia (Author)

História, Ciências, Saúde---Manguinhos
Volume: 20, no. 2
Issue: 2
Pages: 499-520

DOI: 10.1590/S0104-59702013005000007

Outside Links

WorldCat

Google Scholar

JSTOR

Academia.edu

Pharmaceutical industry Pharmacology Textbooks Chemical drugs Medicine 21st century 20th century, late

This article analyzes the presentation of pharmacology as a science in the textbook by Louis Goodman and Alfred Gilman, updated and reprinted many times between 1941 and 2006. In the first editions, pharmacology was characterized as the science of drugs and related to other areas of knowledge; the history of drug development, the role of this science in its social context and its relationship with industry were stressed. In the following editions, these aspects were minimized, almost disappearing in the 11th (2006). The treatment of historical aspects may contribute to understanding the development of pharmacology, as well as the material on relationships with industry and society is important when reflecting on the criteria for using drugs.

...More

Citation URI

https://data.isiscb.org/isis/citation/CBB001420651/

Citations Indexes

Similar Citations

Book Graham Dutfield; (2020)
That high design of purest gold : A critical history of the pharmaceutical industry, 1880-2020 (/isis/citation/CBB895555531/)

Article Quirke, Viviane; (2006)
Putting Theory into Practice: James Black, Receptor Theory and the Development of the Beta-Blockers at ICI, 1958--1978 (/isis/citation/CBB000773951/)

Article Jacalyn Duffin; (2020)
The Yew Tree and the Crab: A Case Study of Big Pharma, Small Pharma, and an Anti-Cancer Drug (/isis/citation/CBB756855341/)

Chapter Daemmrich, A.; Greene, J.; (2010)
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance (/isis/citation/CBB001221031/)

Book Avorn, Jerry; (2004)
Powerful Medicines: The Benefits, Risks and Costs of Prescription Drugs (/isis/citation/CBB000830813/)

Article Andrea M. Bertotti; Skye A. Miner; (April 2019)
Constructing contentious and noncontentious facts: How gynecology textbooks create certainty around pharma-contraceptive safety: Research Note (/isis/citation/CBB188878802/)

Article Daemmrich, A.; (2007)
Pharmaceutical Regulation in the United States and Europe (/isis/citation/CBB001221028/)

Article Schwabl, Herbert; (2013)
The Mercury Puzzle: Tibetan Medicines and the Pharmaceutical Regulations in the European Union--Assessments and Opportunities (/isis/citation/CBB001510480/)

Article Tyabji, Nasir; (2012)
Negotiating Nonalignment: Dilemmas Attendant on Initiating Pharmaceutical Production in India (/isis/citation/CBB001230795/)

Book Gabriel, Joseph M.; (2014)
Medical Monopoly: Intellectual Property Rights and the Origins of the Modern Pharmaceutical Industry (/isis/citation/CBB001422032/)

Book Bürgi, Michael; (2011)
Pharmaforschung im 20. Jahrhundert: Arbeit an der Grenze zwischen Hochschule und Industrie (/isis/citation/CBB001420913/)

Article Hüntelmann, Axel C.; (2013)
A Different Mode of Marketing? The Importance of Scientific Articles in the Marketing Process of Salvarsan (/isis/citation/CBB001320752/)

Article Aschoff, Jürgen C.; (2013)
A Physician's View on Legal Aspects of the Contemporary Medical Use of Mercury in Germany (/isis/citation/CBB001510481/)

Book Greene, Jeremy Alan; (2014)
Generic: The Unbranding of Modern Medicine (/isis/citation/CBB001552637/)

Thesis Bowers, Neil Thomas; (2006)
A Historical Discourse Analysis of the Cancerous and Non-Cancerous Body in Secondary Biology Textbooks (/isis/citation/CBB001560997/)

Article Alan Mackintosh; (2016)
The Patent Medicines Industry in Late Georgian England: A Respectable Alternative to both Regular Medicine and Irregular Practice (/isis/citation/CBB566583777/)

Article Greene, Jeremy A.; (2011)
What's in a Name? Generics and the Persistence of the Pharmaceutical Brand in American Medicine (/isis/citation/CBB001230383/)

Article Thoms, Ulrike; (2013)
Standardizing Selling. Pharmaceutical Marketing, the Pharmaceutical Company and the Marketing Expert (1900--1980) (/isis/citation/CBB001320755/)

Article Greene, Jeremy A.; (2005)
Releasing the Flood Waters: Diuril and the Reshaping of Hypertension (/isis/citation/CBB000800013/)

Book Kaushik Sunder Rajan; (2017)
Pharmocracy: Value, Politics, and Knowledge in Global Biomedicine (/isis/citation/CBB643725178/)

Comments

{{ comment.created_by.username }} on {{ comment.created_on | date:'medium' }}